Shifting From Systemic to Precision-Targeted Complement Therapies: Opportunities and Hurdles.

Eur J Immunol · 2026 · PMC13281374 · PMID 42319133

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

While these developments indicate a positive trend toward improved economic sustainability, overall treatment costs remain high.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.